Unicycive Reports Key Findings of UNI-494 Efficacy in Preclinical Animal Model of Geographic Atrophy

November 21, 2022

https://www.globenewswire.com/news-release/2022/11/21/2559737/0/en/Unicycive-Reports-Key-Findings-of-UNI-494-Efficacy-in-Preclinical-Animal-Model-of-Geographic-Atrophy.html

Treatment with UNI-494 improved contrast vision in animal models of geographic atrophy (GA)

GA is an advanced form of Age-related Macular Degeneration (AMD) and there are currently no
FDA-approved drugs to slow the progression of AMD

Read more at globenewswire.com

Related news for (UNCY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.